Prudential Financial Inc. lessened its position in shares of LHC Group (NASDAQ:LHCG) by 23.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 40,252 shares of the health services provider’s stock after selling 12,500 shares during the period. Prudential Financial Inc. owned approximately 0.22% of LHC Group worth $2,855,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently modified their holdings of LHCG. BlackRock Inc. increased its position in LHC Group by 18.1% during the 2nd quarter. BlackRock Inc. now owns 2,325,510 shares of the health services provider’s stock worth $157,879,000 after purchasing an additional 356,014 shares in the last quarter. Vanguard Group Inc. increased its position in LHC Group by 2.2% during the 2nd quarter. Vanguard Group Inc. now owns 1,464,057 shares of the health services provider’s stock worth $99,395,000 after purchasing an additional 32,049 shares in the last quarter. Dimensional Fund Advisors LP increased its position in LHC Group by 1.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,275,663 shares of the health services provider’s stock worth $86,604,000 after purchasing an additional 13,347 shares in the last quarter. Ameriprise Financial Inc. increased its position in LHC Group by 6.7% during the 2nd quarter. Ameriprise Financial Inc. now owns 578,956 shares of the health services provider’s stock worth $39,306,000 after purchasing an additional 36,218 shares in the last quarter. Finally, State Street Corp increased its position in LHC Group by 7.5% during the 2nd quarter. State Street Corp now owns 420,839 shares of the health services provider’s stock worth $28,568,000 after purchasing an additional 29,464 shares in the last quarter. 85.25% of the stock is owned by institutional investors.

In other LHC Group news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the transaction, the chief operating officer now directly owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 14.80% of the company’s stock.

LHC Group (NASDAQ LHCG) opened at $65.43 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. LHC Group has a 12-month low of $41.66 and a 12-month high of $76.14. The stock has a market cap of $1,195.99, a P/E ratio of 28.08, a price-to-earnings-growth ratio of 1.94 and a beta of 0.69.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The firm had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. During the same period in the prior year, the company posted $0.54 EPS. The company’s revenue was up 18.2% on a year-over-year basis. equities research analysts predict that LHC Group will post 2.4 earnings per share for the current year.

A number of equities analysts recently issued reports on the stock. Royal Bank Of Canada reiterated a “buy” rating and set a $70.00 price objective on shares of LHC Group in a research report on Wednesday, September 6th. BidaskClub upgraded shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective for the company in a research report on Saturday, August 5th. William Blair reiterated an “outperform” rating on shares of LHC Group in a research report on Tuesday, November 21st. Finally, ValuEngine cut shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Friday. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. LHC Group presently has a consensus rating of “Buy” and an average price target of $77.10.

ILLEGAL ACTIVITY NOTICE: “LHC Group (LHCG) Stake Decreased by Prudential Financial Inc.” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.watchlistnews.com/lhc-group-lhcg-stake-decreased-by-prudential-financial-inc/1740708.html.

LHC Group Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.